AI-generated analysis. Always verify with the original filing.
Harvard Bioscience, Inc. filed an 8-K on March 12, 2026, under Item 2.02 referencing Exhibit 99.1 Press Release, indicating disclosure of results of operations or earnings information not deemed 'filed' under Section 18 of the Securities Exchange Act. The filing includes Items 2.02 and 9.01 with Exhibit 99.1.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 193
. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by Harvard Bioscience, Inc. on March 12, 2026 104 Cover